Vaccine
A vaccine is a biological preparation that gives active acquired immunity against a particular infectious or malignant disease. Scientists have studied the safety and effectiveness of vaccines carefully. A vaccine usually contains something that looks like a disease-causing microorganism. It is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. This helps the immune system learn to recognize the threat, destroy it, and fight off matching microorganisms it meets later.
Vaccines can be prophylactic, which means they prevent or lessen the effects of a future infection by a natural or "wild" pathogen. They can also be therapeutic, which means they fight a disease that has already happened, such as cancer. Some vaccines provide full sterilizing immunity, which stops an infection from happening at all.
Giving vaccines is called vaccination. It is the best way to prevent infectious diseases. Immunity spread through vaccination helped lead to the worldwide eradication of smallpox. Vaccines have also kept diseases such as polio, measles, and tetanus away from much of the world. The World Health Organization (WHO) reports that licensed vaccines are available for twenty-five different preventable infections.
The history of vaccines goes back a long way. The first recorded use of inoculation to prevent smallpox (see variolation) happened in the 16th century in China, and the earliest hints of this practice appeared there in the 10th century. Smallpox was also the first disease for which a vaccine was made. In 1721, Lady Mary Wortley Montagu brought the practice of inoculation against smallpox from Turkey to Britain. The words vaccine and vaccination come from Variolae vaccinae (smallpox of the cow), a term created by Edward Jenner. Jenner developed the idea of vaccines and made the first one, using cowpox. In 1881, Louis Pasteur suggested extending these words to cover new protective inoculations, to honor Jenner. The science of making and producing vaccines is called vaccinology.
Effectiveness
Scientists agree that vaccines are very safe and work well to fight infectious diseases. The immune system sees vaccine agents as foreign, destroys them, and remembers them. If the virulent version of an agent appears later, the body knows its protein coat and is ready. It stops the agent before it can enter cells. If needed, it destroys infected cells before the agent can multiply.
Measles was once very common in the United States. After new vaccines were introduced, the number of cases dropped to very few each year. Vaccines helped end smallpox, which was one of the most contagious and dangerous diseases for humans. Diseases such as polio, chickenpox, and typhoid are now much less common than they were a hundred years ago. When most people are vaccinated, an outbreak is much harder to start or spread. This protection for everyone is called herd immunity. Scientists are working to wipe out polio with an eradication campaign. However, reaching every child, cultural misunderstandings, and disinformation have made it hard to reach the goal on time. Vaccines also help fight germs that resist medicine. By greatly reducing pneumonia caused by Streptococcus pneumoniae, vaccine programs have lowered infections that resist penicillin and other common antibiotics.
Vaccines do not always work. Protection can fail because of the vaccine itself or how it was given. It can also fail when a person's body does not respond well. This happens to a small number of people because of genetics, age, health, and nutrition. One type of primary immunodeficiency, X-linked agammaglobulinemia, stops the body from making antibodies against a pathogen. This happens because an enzyme needed for B cell development is missing. The body's innate immunity can respond within about twelve hours. However, adaptive immunity can take one to two weeks to fully develop, so a person can still become sick during that time. Vaccines may give partial or temporary protection. Even so, they can still lower the chance of infection across a group of people. They can also reduce the mortality rate and morbidity and help people recover faster. Older people often respond less strongly than younger people. This pattern is known as Immunosenescence, so Adjuvants are often used to boost their response. A vaccine's efficacy depends on the disease, the strain, whether the vaccination schedule was followed, and personal factors such as genetics. If a vaccinated person still gets the disease, it is called a breakthrough infection. These infections are usually milder and less likely to spread.
Safety
Main article: Adverse vaccine event
Vaccines given to children, teenagers, and adults are generally safe. Any side effects are usually mild. How common side effects are depends on the vaccine. Common ones include fever, pain where the shot was given, and muscle aches. Some people may be allergic to an ingredient in a vaccine. The MMR vaccine is rarely linked to febrile seizures. Serious side effects are extremely rare. The Varicella vaccine is rarely linked to problems in people with immunodeficient conditions. Rotavirus vaccines are moderately linked to intussusception. At least 19 countries have no-fault programs that help people who have serious side effects from vaccines. The United States' program is called the National Childhood Vaccine Injury Act. The United Kingdom uses the Vaccine Damage Payment.
Many things about a person can affect how serious an infection is and how well a vaccine works. These include genetics, health, sensitivities, allergies, immune competence, age, economic impact, and cultural environment. Older people (over 60), people who are allergen-hypersensitive, and obese people may not respond as strongly to vaccines. This is called immunogenicity. Because of this, they may need different vaccine types or repeated booster vaccinations. These help limit virus transmission.
Types
Vaccines usually contain weakened or killed germs, or pure parts made from them. Some vaccines use live germs that have been weakened so they are less harmful. Most of these are viruses, but some are bacteria. Examples include yellow fever, measles, mumps, rubella, and typhoid. The tuberculosis vaccine uses a weakened form of a contagious germ. A weakened live form of Yersinia pestis is used against plague. Other vaccines use germs that have been killed or made inactive, such as the polio vaccine, hepatitis A vaccine, rabies vaccine, and most influenza vaccines.
Some vaccines use toxoids. These are made from harmful substances that germs produce, not from the germs themselves. Examples include tetanus and diphtheria. Subunit vaccines use only a small piece of a germ, such as the surface proteins of the hepatitis B virus or the human papillomavirus (HPV). Conjugate vaccines join parts of bacteria to proteins so the immune system can recognize them. Heterologous vaccines use germs from other animals that cause little or no disease in people. Jenner used cowpox against smallpox in this way. The BCG vaccine is made from Mycobacterium bovis and is used against tuberculosis.
Genetic vaccines help cells make a protein that triggers an immune response. This group includes viral vector vaccines, RNA vaccines, and DNA vaccines. Some of the COVID-19 vaccines are RNA vaccines, and they were used during the COVID-19 pandemic. Many newer approaches are also being studied. These include dendritic cell vaccines, bacterial vector vaccines, and inverse vaccines, which teach the immune system not to respond to certain substances. Most vaccines are made from weakened or killed germs, but synthetic vaccines are made mainly from synthetic peptides, carbohydrates, or antigens.
Valence
Vaccines can be monovalent (also called univalent) or multivalent (also called polyvalent). A monovalent vaccine protects against one antigen or one microorganism. A multivalent vaccine protects against two or more strains of the same microorganism, or against two or more microorganisms. The number can be shown with a prefix, such as bivalent, trivalent, or tetravalent/quadrivalent. In some cases, a monovalent vaccine may be better at quickly building a strong immune response.
When two or more vaccines are mixed together, they can sometimes get in each other's way. This happens most often with live attenuated vaccines. One part can be stronger than the others and slow down their growth and immune response. This was seen with the trivalent Sabin polio vaccine. The amount of serotype 2 virus had to be lowered so it would not stop the serotype 1 and 3 viruses from taking hold. To fix this, the doses of serotypes 1 and 3 were increased in the early 1960s. A 2001 study also found this problem with dengue vaccines. The DEN-3 serotype became dominant and reduced the response to DEN-1, -2 and -4.
Main article: Immunologic adjuvant
Vaccines often contain adjuvants, which help the body build a stronger response. For example, tetanus toxoid is usually mixed with alum, which works better than tetanus toxoid alone. Before the 1990 Persian Gulf campaign, a whole cell pertussis vaccine was used as an adjuvant for anthrax vaccine, and it helped the body respond more quickly. Vaccines may also contain preservatives to stop bacteria or fungi from getting in. Other ingredients, such as aluminum salts or gels, can help the body respond sooner and more strongly. Antibiotics stop bacteria from growing during making and storage. Some vaccines contain egg protein, including the influenza vaccine and the yellow fever vaccine, because they are made using chicken eggs. Formaldehyde is used to weaken bacterial products and to kill unwanted germs. Monosodium glutamate (MSG) and 2-phenoxyethanol help vaccines stay the same when they are exposed to heat, light, acids, or moisture.
Many vaccines need preservatives to prevent serious problems, such as infection by Staphylococcus. In a 1928 incident, a diphtheria vaccine without a preservative badly harmed a number of children. Several preservatives are used, including thiomersal, phenoxyethanol, and formaldehyde. Thiomersal works well against bacteria and helps vaccines stay stable. However, it contains mercury, so the US, the European Union, and some other wealthy countries stopped using it in children's vaccines as a precaution. It was removed from most vaccines, except some multi-use influenza vaccines, which contain only a very tiny amount of mercury in each dose. Some controversial claims say thiomersal causes autism, but no convincing scientific evidence supports this. A long study of children, lasting more than ten years, found that the MMR vaccine does not cause autism and may even slightly lower the risk.
Nomenclature
Vaccines often have short forms, called abbreviations. Many of these are used widely, though no single group sets them for the whole world. In the United States, vaccine abbreviations are well known and are also used in other countries. The Centers for Disease Control and Prevention has a long list of them on its website, and anyone can read it for free. The CDC says its staff, ACIP work groups, the editors of the Morbidity and Mortality Weekly Report (MMWR) and Epidemiology and Prevention of Vaccine-Preventable Diseases (the Pink Book), ACIP members, and groups that work with the ACIP helped set these abbreviations.
For example, "DTaP" is a vaccine against diphtheria, tetanus, and pertussis. "DT" and "Td" are shorter versions that cover some of these diseases. Capital letters mean full-strength doses. Lowercase "d" and "p" mean smaller doses, which are used for teens and adults. The "a" in DTaP means "acellular," which means the pertussis part contains only a small piece of the pertussis germ. The United States Adopted Name system also follows certain rules for the word order of vaccine names. It puts head nouns first and adjectives after them. This is why the name for "OPV" is "poliovirus vaccine live oral" instead of "oral poliovirus vaccine."
Licensing
See also: Vaccine trial
A vaccine is licensed, or approved for use, after it is developed and tested in Phases I–III of clinical trials. These tests show that it is safe, works, and protects people for a long time. Vaccines are given to healthy people, so the safety rules are very strict. The World Health Organization (WHO) created international guidelines for making and quality control of vaccines. Countries can use these guidelines to make their own licensing rules. Review groups such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) check a vaccine before a company can receive a license. When developing countries follow WHO guidelines, each country issues its own license and watches over the vaccine. Governments and health workers also need to help people trust vaccines. A new vaccine is often in short supply at first, so plans are made to decide who gets it first.
Vaccines sent around the world through the United Nations Children's Fund (UNICEF) must be checked by the WHO. They must meet international standards for quality, safety, and effectiveness. Makers must follow Good Manufacturing Practice (GMP). Countries also keep watching for side effects through postmarketing surveillance. In the European Union, a vaccine for a disease such as seasonal influenza may be approved for all member states, for some of them, or for only one country. The Committee for Medicinal Products for Human Use (CHMP) guides this process. In the United States, the FDA follows the same steps it uses for the approval process for prescription drugs. It also requires a Biologics License Application. In India, the Drugs Controller General approves vaccines. This person leads the Central Drugs Standard Control Organization. Because not all adverse events are known early on, makers run Phase IV studies. The FDA also uses the Vaccine Adverse Event Reporting System to track safety concerns.
Scheduling
Main article: Vaccination schedule
For information about vaccine rules in different countries, see Vaccination policy.
Children are usually given vaccines as soon as their bodies are ready to fight the diseases. Some vaccines need extra "booster" shots to keep protection strong, so schedules can be complicated. The Strategic Advisory Group of Experts makes advice for the whole world. Each country's advisory committee changes this advice to fit its own needs. These needs include how a disease spreads, whether people accept vaccines, fairness for local communities, and how much money and help a country has. In the United States, the Advisory Committee on Immunization Practices helps the Centers for Disease Control and Prevention decide which vaccines to add to the schedule. Children are routinely recommended vaccines against hepatitis A, hepatitis B, polio, mumps, measles, rubella, diphtheria, pertussis, tetanus, HiB, chickenpox, rotavirus, influenza, meningococcal disease, and pneumonia.
There are many vaccines and boosters, so it can be hard for families to keep track of them all. To help, some reminder systems have been started. Many combination shots are also available, such as the Pentavalent vaccine and the MMRV vaccine. These protect against several diseases at once. Vaccines are also recommended for other ages, most often for measles, tetanus, influenza, and pneumonia. Pregnant women are often checked to see if they are still protected against rubella. As of 2011, the human papillomavirus vaccine was recommended in the US, and as of 2009 it was recommended in the UK. For older people, the advice focuses on pneumonia and influenza. These illnesses can be more serious for them. In 2006, a vaccine was introduced against shingles, an illness caused by the chickenpox virus that usually affects older people.
Economics of development
Main article: Economics of vaccines
Making vaccines can be hard because of money. Many diseases that need vaccines the most, such as HIV, malaria, and tuberculosis, mostly exist in poor countries. In the United States, companies often earn little money from vaccines, but the risks are large. Most vaccine development so far has been paid for by governments, universities, and non-profit groups. Many vaccines have been very cost effective and good for public health. The number of vaccines given has grown a lot in recent decades. This growth, especially in the number of vaccines children get before they start school, may be due more to government rules and support than to money-making goals.
According to the World Health Organization (WHO), the biggest barrier to making vaccines in less developed countries has not been patents. Instead, it has been the large amounts of money, infrastructure, and trained workers needed to start making them. Vaccines are complex mixtures of biological substances, so unlike prescription drugs, there are no true generic vaccines. A new factory's vaccine must be fully tested by its maker to show it is safe and works. For most vaccines, certain ways of making them are patented, but other methods can be used if there are the research facilities and skilled workers to do so. For a few newer vaccines, such as the human papillomavirus vaccine, patents may add an extra barrier. In 2021, during the COVID-19 pandemic, more vaccines were urgently needed. The World Trade Organization and governments around the world discussed setting aside intellectual property rights and patents on COVID-19 vaccines. The goal was to remove barriers so that affordable COVID-19 medical products, including vaccines and medicines, could reach people in time.
Production
Making vaccines is very different from other kinds of factory work, such as pharmaceutical manufacturing. Vaccines are given to millions of people, and most of them are healthy, so the process must follow very strict rules. A vaccine factory can cost US$50 to $500 million to build. It needs special equipment, clean rooms, and containment rooms. Skilled workers are hard to find around the world. Apart from Brazil, China, and India, many developing countries do not have schools that can train enough qualified people. Because of this, vaccine makers there often hire workers from other countries.
Making a vaccine has several steps. First, the antigen is grown. Viruses are grown in chicken eggs or in human cells grown in a lab. Bacteria are grown in bioreactors. Next, the antigen is separated from the cells. Then, adjuvants, stabilizers, and preservatives are added. The last step, fill and finish, means filling small bottles called vials and packaging them. This step often slows down the whole process. The largest vaccine makers include Merck, Sanofi, GlaxoSmithKline, Pfizer, and Novartis. Some developing countries are also making more of their own vaccines. These include Serum Institute of India in India and Sinopharm (CNPGC) in China.
Delivery systems
One of the most common ways to give vaccines is injection. Scientists hope new delivery systems could make vaccines safer and easier to give. Two areas of research are liposomes and ISCOM (immune stimulating complex). Another idea is a microneedle approach. It uses tiny pointed projections to make small paths for the vaccine through the skin. A needle-free patch is also being tested on animals. It is about the size of a stamp and works like an adhesive bandage. It has about 20,000 tiny projections per square centimeter. This dermal method may work better than injection and need less vaccine.
Vaccines taken by mouth have also been an important development. By the 1930s, people were interested in an oral typhoid fever vaccine. An earlier oral vaccine against bacteria had once been controversial. An oral polio vaccine worked well when volunteers without formal training gave it. It was easy and quick to give. Oral vaccines have some advantages. They carry no risk of blood contamination. As solids, they are often more stable and less likely to be damaged by freezing. This stability reduces the need for a "cold chain," which is the set of steps used to keep vaccines at the right temperature from the factory to the person receiving them. This may lower costs.
In veterinary medicine
See also: Influenza vaccine § Veterinary use, and Vaccination of dogs
Animals are vaccinated to keep them from getting sick and to stop diseases from spreading to people. Pets and farm animals are often vaccinated, and sometimes wild animals are too. In one method, vaccine is placed in food and spread in areas where a disease is common. This has been used to try to control rabies in raccoons. Where rabies is found, dogs may be required by law to be vaccinated against it. Other dog vaccines protect against canine distemper, canine parvovirus, infectious canine hepatitis, adenovirus-2, leptospirosis, Bordetella, canine parainfluenza virus, and Lyme disease, among others. Some veterinary vaccines have also been given to people, on purpose or by accident. A few of these caused illness, most notably brucellosis. Such cases are rarely reported, so little is known about how safe they are. People may have come into contact more often with germs they do not usually carry, such as Bordetella bronchiseptica, because of spray vaccines given in veterinary clinics.
Vaccines can make animal testing harder, because both infection and vaccination cause the body to make antibodies. To solve this, special marker vaccines are made from germs that are missing at least one epitope found in the wild version. A matching test looks for antibodies against that missing part. This shows whether an animal was vaccinated or infected. These are also called "DIVA vaccines." This method has been used in several countries to remove pseudorabies virus. A test called an ELISA was developed to find the antibodies.
Main article: Marker vaccine
Further information: Vaccination § History, and Inoculation § Origins
Before vaccines existed, people could protect against smallpox by variolation. This meant deliberately infecting people with smallpox virus. According to historian Joseph Needham, Taoists in China used a form of inoculation as early as the 10th century. Some people doubt this claim, because the practice was not written down at the time. The oldest written record of variolation dates back to the fifteenth century in China. Powdered smallpox material was blown up the nose, a method called "nasal insufflation." In 1721, Mary Wortley Montagu had her four-year-old daughter variolated in England after seeing the practice in Turkey.
In 1796, Edward Jenner used material from a milkmaid's cowpox sore to protect an 8-year-old boy, James Phipps, from smallpox. Jenner's vaccine was later shown to be safe, and it could be passed from person to person. Cowpox vaccination was much safer than smallpox inoculation, so the older method was banned in England in 1840. Later, Louis Pasteur developed vaccines in the 1880s. The polio vaccine was developed in the 1950s. A major achievement of the twentieth century was the eradication of smallpox during the 1960s and 1970s.
First generation vaccines are made from whole germs that are either live and weakened, or killed. Live vaccines, such as smallpox and polio vaccines, can trigger strong immune responses. However, weakened germs can sometimes become dangerous again in people whose immune systems are weak, such as those with AIDS. Killed vaccines avoid this risk. Second generation vaccines were developed to be safer. They use specific parts of germs, such as protein pieces from tetanus or diphtheria toxoid. Third generation vaccines include DNA vaccines and RNA vaccines. mRNA vaccines such as BNT162b2 were developed in 2020 and were widely used to fight the COVID-19 pandemic.
Trends
Since at least 2013, scientists have been trying to make new kinds of vaccines. Some copy the outside shape of a virus. They hope this will help vaccines keep working well over time. The same ideas that guide the body's defenses can now be used to make special vaccines against many diseases that are not caught from other people, such as some cancers and autoimmune disorders. For example, the experimental vaccine CYT006-AngQb has been studied as a possible treatment for high blood pressure. Changes in vaccine development are shaped by progress in medical research, demographics, regulatory science, and how governments, cultures, and societies respond.
The idea of making vaccines in transgenic plants was first identified in 2003. Plants such as tobacco, potato, tomato, and banana can have genes added so that they make vaccines for people. In 2005, bananas were developed that make a human vaccine against hepatitis B.
Vaccine hesitancy
Main article: Anti-vaccine activism
Vaccine hesitancy means waiting to accept vaccines, or saying no to them, even when vaccines are available. A person might refuse all vaccines, delay them, accept them but feel unsure, or take some vaccines but not others. Scientists almost all agree that vaccines are generally safe and work well.
Vaccine hesitancy can lead to outbreaks of disease and to people dying from vaccine-preventable diseases. Because of this, the World Health Organization called vaccine hesitancy one of the top ten threats to world health in 2019.

Quiz time!
4 questions about Vaccine
What is a vaccine often made from?
Pictures
Keep exploring
This article is a child-friendly adaptation of the Wikipedia article on Vaccine, available under CC BY-SA 4.0.
Images from Wikimedia Commons. Tap any image to view credits and license.